Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and evaluation of quinoline- O -carbamate derivatives as multifunctional agents for the treatment of Alzheimer’s disease
Hongsong Chen, Jing Mi, Sen Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 17

Showing 17 citing articles:

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 34
Quinoline–sulfonamides as a multi-targeting neurotherapeutic for cognitive decline: in vitro, in silico studies and ADME evaluation of monoamine oxidases and cholinesterases inhibitors
Saquib Jalil, Zahid Hussain, Syed Mobashir Ali Abid, et al.
RSC Advances (2024) Vol. 14, Iss. 13, pp. 8905-8920
Open Access | Times Cited: 6
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Quinoline analogs: multifaceted heterocyclic compounds with varied synthetic strategies and potent antitubercular properties
Rajendra Prasad Pakhariya, Ayushi Bhatnagar, Gangotri Pemawat
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3646-3663
Open Access
Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD
Yuting Li, Qiyao Zhang, Xinxin Wang, et al.
Bioorganic Chemistry (2025), pp. 108245-108245
Closed Access
Quinoline: A versatile bioactive scaffold and its molecular hybridization
Ibrahim A. Bala, Ohoud F. Al Sharif, Abdullah M. Asiri, et al.
Results in Chemistry (2024) Vol. 7, pp. 101529-101529
Open Access | Times Cited: 4
Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer’s disease
Chuanyu Yu, Xueyan Liu, Bingxiang Ma, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 3
A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer's disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 2
Closed Access | Times Cited: 3
Design, synthesis and biological evaluation of bakuchiol derivatives as multi-target agents for the treatment of Alzheimer's disease
Xiaoqing Zhang, Yan-Nan Xiang, Qin Tian, et al.
Fitoterapia (2024) Vol. 174, pp. 105867-105867
Closed Access | Times Cited: 2
Tailored Melatonin- and Donepezil-Based Hybrids Targeting Pathognomonic Changes in Alzheimer’s Disease: An In Vitro and In Vivo Investigation
Rositsa Mihaylova, Violina T. Angelova, Jana Tchekalarova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5969-5969
Open Access | Times Cited: 2
Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer’s diseases therapy
Osama M. Soltan, Kamal S. Abdelrahman, Amr K.A. Bass, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107651-107651
Closed Access | Times Cited: 2
Synthesis of Ethyl Pyrimidine-Quinolincarboxylates Selected from Virtual Screening as Enhanced Lactate Dehydrogenase (LDH) Inhibitors
Iván Díaz, Sofı́a Salido, Manuel Nogueras, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9744-9744
Open Access | Times Cited: 2
Therapy and diagnosis of Alzheimer's disease: from discrete metal complexes to metal–organic frameworks
Amalia García-García, Sara Rojas, Antonio Rodríguez‐Diéguez
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 30, pp. 7024-7040
Open Access | Times Cited: 7
The Versatile and Strategic O-Carbamate Directed Metalation Group in the Synthesis of Aromatic Molecules: An Update
Ross D. Jansen‐van Vuuren, Susana Liu, M. A. Jalil Miah, et al.
Chemical Reviews (2024) Vol. 124, Iss. 12, pp. 7731-7828
Open Access | Times Cited: 1
Synthesis of Novel Oxime and Benzofuran Chemical Frameworks Possessing Potent Anticholinesterase Activity: A SAR Study Related to Alzheimer Disease
Anıl Yılmaz, Murat Koca, Mehmet Boğa, et al.
ChemistrySelect (2023) Vol. 8, Iss. 30
Closed Access | Times Cited: 2
Recent Advancements in the Treatment of Alzheimer’s Disease: A Multitarget-directed Ligand Approach
Sumit Kumar, Amol T. Mahajan, Ramesh Ambatwar, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 37, pp. 6032-6062
Closed Access | Times Cited: 2
Synthesis, Antioxidant, and Anticancer Studies of New 1,3,4‐Oxadiazole Derivatives Linked to Benzoquinoline
Ahmed A. Fadda, Eslam R. El‐Sawy, T. A. Zidan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 28
Closed Access
Designing of quinoline-based esterase inhibitor: Synthesis, crystal structure, DFT calculations, and molecular docking
Asif Jamal, Md. Serajul Haque Faizi, Hela Ferjani
Journal of Molecular Structure (2024) Vol. 1319, pp. 139540-139540
Closed Access
A high-throughput system for drug screening based on the movement analysis of zebrafish
Xinkai Zhao, Ziyu Li, Bingbing Cao, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e36495-e36495
Open Access
Page 1

Scroll to top